Please assess the completion status of the following clinical trial:

Trial Title: Treatment Effect of Saxagliptin Compared With Placebo in Patients With Type 2 Diabetes and Renal Impairment

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosed with type 2 diabetes~* Documented history of CrCl \<50 ml/min within the 3 months prior to enrollment~* HbA1c ≥7.0% and ≤11.0%~Exclusion Criteria:~* Type 1 diabetes, history of diabetic ketoacidosis or hyposmolar non-ketonic coma~* Previous or current treatment with any DPP-IV inhibitor and/or GLP-1 mimetic.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Saxa (Type: EXPERIMENTAL): Saxagliptin
- Placebo (Type: NO_INTERVENTION): Placebo to match

Based on this trial design, predict the completion outcome and termination type (if applicable).